The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.

Item
http://www.wikidata.org/entity/Q37711317
Liver steatosis in hepatitis C patientsChanges in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES.A comparative study of serum lipid contents in pre and post IFN-alpha treated acute hepatitis C patients.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.Diabetes and Glucose Metabolism in Thalassemia Major: An Update.Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C.Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes.Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study.Genotype specific peripheral lipid profile changes with hepatitis C therapy.Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus.Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b.The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C.
P2860

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.

Item
http://www.wikidata.org/entity/Q37711317
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of pegylated interf ...... chronic hepatitis C patients.
@en
The impact of pegylated interf ...... chronic hepatitis C patients.
@nl
type
label
The impact of pegylated interf ...... chronic hepatitis C patients.
@en
The impact of pegylated interf ...... chronic hepatitis C patients.
@nl
prefLabel
The impact of pegylated interf ...... chronic hepatitis C patients.
@en
The impact of pegylated interf ...... chronic hepatitis C patients.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
The impact of pegylated interf ...... chronic hepatitis C patients.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932